Ratings by UBS (Douglas Schenkel)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 10/22/2026 | Thermo Fisher Scientific | TMO | Maintain | Buy (Buy) |
|
Details | ||
| 10/22/2026 | Danaher | DHR | Maintain | Buy (Buy) |
|
Details | ||
| 9/29/2026 | Repligen | RGEN | Maintain | Buy (Buy) |
|
Details | ||
| 9/9/2026 | Veracyte, Inc | VCYT | Maintain | Buy (Buy) |
|
Details | ||
| 9/9/2026 | Tempus AI Inc | TEM | New Coverage | Neutral (N/A) |
64.29 (67.62) |
5.18% | Details | |
| 9/9/2026 | Natera | NTRA | New Coverage | Buy (N/A) |
324.14 (403.95) |
24.62% | Details | |
| 9/9/2026 | Myriad Genetics | MYGN | New Coverage | Neutral (N/A) |
3.18 (5.82) |
83.02% | Details | |
| 9/9/2026 | Guardant Health | GH | New Coverage | Buy (N/A) |
160.98 (169.08) |
5.03% | Details | |
| 9/9/2026 | HeartFlow | HTFL | New Coverage | Neutral (N/A) |
47.75 (56.71) |
18.76% | Details | |
| 9/9/2026 | GRAIL, Inc. | GRAL | New Coverage | Buy (N/A) |
79.10 (132.55) |
67.57% | Details | |
| 9/9/2026 | Caris Life Sciences Inc | CAI | New Coverage | Neutral (N/A) |
24.82 (32.00) |
28.93% | Details | |
| 9/9/2026 | West Pharmaceutical | WST | New Coverage | Buy (N/A) |
337.75 (392.15) |
16.11% | Details | |
| 9/9/2026 | Stevanato Group S.p.A. | STVN | New Coverage | Neutral (N/A) |
20.32 (19.49) |
-4.08% | Details | |
| 9/9/2026 | Twist Bioscience | TWST | New Coverage | Neutral (N/A) |
128.06 (139.92) |
9.26% | Details | |
| 9/9/2026 | Pacific Biosciences of California | PACB | New Coverage | Neutral (N/A) |
1.32 (2.11) |
59.85% | Details | |
| 9/9/2026 | 10X Genomics | TXG | New Coverage | Neutral (N/A) |
65.60 (71.55) |
9.07% | Details | |
| 9/9/2026 | Repligen | RGEN | New Coverage | Buy (N/A) |
168.53 (176.93) |
4.98% | Details | |
| 9/9/2026 | Maravai LifeScience Holdings Inc. | MRVI | Maintain | Neutral (N/A) |
|
Details | ||
| 9/9/2026 | Revvity Inc | RVTY | New Coverage | Neutral (N/A) |
127.08 (158.77) |
24.94% | Details | |
| 9/9/2026 | Qiagen NV | QGEN | New Coverage | Neutral (N/A) |
42.38 (50.39) |
18.9% | Details | |
| 9/9/2026 | Waters Corp. | WAT | New Coverage | Buy (N/A) |
402.91 (453.67) |
12.6% | Details | |
| 9/9/2026 | Mettler-Toledo | MTD | New Coverage | Neutral (N/A) |
1325.52 (1670.29) |
26.01% | Details | |
| 9/9/2026 | Illumina | ILMN | New Coverage | Buy (N/A) |
211.06 (269.42) |
27.65% | Details | |
| 9/9/2026 | Bruker | BRKR | New Coverage | Neutral (N/A) |
58.37 (57.59) |
-1.34% | Details | |
| 9/9/2026 | Avantor Inc. | AVTR | New Coverage | Neutral (N/A) |
15.25 (17.29) |
13.38% | Details | |
| 9/9/2026 | Agilent | A | New Coverage | Neutral (N/A) |
146.85 (173.07) |
17.85% | Details | |
| 9/9/2026 | Thermo Fisher Scientific | TMO | Upgrade | Buy (Neutral) |
613.78 (673.82) |
9.78% | Details | |
| 9/9/2026 | Danaher | DHR | New Coverage | Buy (N/A) |
207.66 (230.50) |
11% | Details |
